JESSICA HAMPTON: Open Payments
NPI 1528554144 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,593 in 142 payments from 26 companies in 2025. Trend: 2023 $320 · 2024 $1,298 · 2025 $2,593
Food & beverage: $2,593
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 25 | $401 |
| AstraZeneca Pharmaceuticals LP | 7 | $317 |
| Novo Nordisk Inc | 20 | $313 |
| ABBVIE INC. | 22 | $272 |
| Amgen Inc. | 13 | $232 |
| Lilly USA, LLC | 14 | $228 |
| Ardelyx, Inc. | 4 | $164 |
| Abbott Laboratories | 5 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $67 |
Products named: PREVNAR 20, AIRSUPRA, IBSRELA, Ozempic, MOUNJARO, REPATHA, UBRELVY, Wegovy.
Industry payments across KS — which companies pay providers there.
